Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.
Study Goal
The researchers aimed to evaluate the safety and effectiveness of a supervised walking program in women with primary Sjögren's syndrome (pSS).
Results Summary
The supervised walking program improved cardiorespiratory fitness, exercise tolerance, fatigue, and patient perception of improvement in pSS patients, with no reported adverse effects.
Population
Sedentary women with primary Sjögren's syndrome (pSS).
Effective Dosage
Supervised walking three times a week.
Duration
16 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
supervised walking program | increase | cardiorespiratory fitness | women with primary Sjögren's syndrome (pSS) | - | improvements in | #1 |
supervised walking program | increase | exercise tolerance | women with primary Sjögren's syndrome (pSS) | - | improvements in | #2 |
supervised walking program | decrease | fatigue | women with primary Sjögren's syndrome (pSS) | - | improvements in | #3 |
supervised walking program | increase | patient perception of improvement | women with primary Sjögren's syndrome (pSS) | - | improvements in | #4 |
supervised walking program | no change | feasible | women with primary Sjögren's syndrome (pSS) | - | was demonstrated to be | #5 |
supervised walking program | no change | safe | women with primary Sjögren's syndrome (pSS) | - | was demonstrated to be | #6 |
OBJECTIVE: The aim of this study was to evaluate the safety and effectiveness of a supervised walking program in women with primary Sjögren's syndrome (pSS). METHODS: Forty-five sedentary women fulfilling the American European Consensus Criteria for pSS were randomized to a training group (TG, n = 23) or control group (CG, n = 22). Patients in the TG were submitted to supervise walking three times a week for 16 weeks. The patients of the CG were instructed to not perform any kind of regular physical exercise. Physical fitness [maximum oxygen uptake (VO RESULTS: After 16 weeks, the mean change of VO CONCLUSIONS: This supervised walking program was demonstrated to be feasible and safe with improvements in cardiorespiratory fitness, exercise tolerance, fatigue, and patient perception of improvement in pSS patients. TRIAL REGISTRATION: Clinical Trials.gov ID, number NCT02370225.